These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33489449)

  • 1. TaibUVID nutritional supplements help rapid cure of COVID-19 infection and rapid reversion to negative nasopharyngeal swab PCR: for better public prophylaxis and treatment of COVID-19 pandemic.
    El Sayed SM; Aboonq MS; Aljehani YT; Hassan MA; Abou El-Magd RM; Abdelrahman AI; El-Tahlawi R; Nabo MMH; Yousef RS; Mahmoud AA; Elsayed YY; Abu-Elnaga M; Soliman TM; Abdel-Gawad AR; Elshazley M; Baghdadi H; El-Sawy S; Mahmoud HS; El-Anzi ME; Alharbi MB
    Am J Blood Res; 2020; 10(6):397-406. PubMed ID: 33489449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising preventive and therapeutic effects of TaibUVID nutritional supplements for COVID-19 pandemic: towards better public prophylaxis and treatment (A retrospective study).
    El Sayed SM; Aboonq MS; El Rashedy AG; Aljehani YT; Abou El-Magd RM; Okashah AM; El-Anzi ME; Alharbi MB; El-Tahlawi R; Nabo MMH; Yousef RS; Elshazley M; Abu-Elnaga M; Mahmoud HS; El-Alaf H; Abdelrahman AI; Abdel-Gawad AR; Soliman TM
    Am J Blood Res; 2020; 10(5):266-282. PubMed ID: 33224571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.
    Chen LD; Li H; Ye YM; Wu Z; Huang YP; Zhang WL; Lin L
    BMC Infect Dis; 2020 Jul; 20(1):517. PubMed ID: 32677909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of the first patient with imported Middle East respiratory syndrome in China].
    Ling Y; Qu R; Luo Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):630-4. PubMed ID: 26255008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An uncommon manifestation of COVID-19 pneumonia on CT scan with small cavities in the lungs: A case report.
    Chen J; Peng S; Zhang B; Liu Z; Liu L; Zhang W
    Medicine (Baltimore); 2020 Jul; 99(28):e21240. PubMed ID: 32664179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical Chest Computed Tomography Finding of Predominant Interstitial Thickening in a Patient with Coronavirus Disease 2019 (COVID-19) Pneumonia.
    Lau JYC; Khoo HW; Hui TCH; Kaw GJL; Tan CH
    Am J Case Rep; 2020 Sep; 21():e926781. PubMed ID: 32952147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Migratory pulmonary ground glass opacities caused by SARS-CoV-2 infection in a patient on B-cell depletion therapy].
    Wang SY; Wang YM; Liu M; Zhao L; Cao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1233-1239. PubMed ID: 38044051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [COVID-19 associated pneumonia despite repeatedly negative PCR-analysis from oropharyngeal swabs].
    Hornuss D; Laubner K; Monasterio C; Thimme R; Wagner D
    Dtsch Med Wochenschr; 2020 Jun; 145(12):844-849. PubMed ID: 32403153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [COVID-19 associated pneumonia despite repeatedly negative PCR-analysis from oropharyngeal swabs].
    Hornuss D; Laubner K; Monasterio C; Thimme R; Wagner D
    Pneumologie; 2020 Sep; 74(9):615-620. PubMed ID: 32916744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical application effect of modified nasopharyngeal swab sampling for 2019 novel coronavirus nucleic acid detection].
    Ma SY; Luo YM; Hu TY; You ZC; Sun JG; Yu SY; Yuan ZQ; Peng YZ; Luo GX; Xu Z
    Zhonghua Shao Shang Za Zhi; 2020 Aug; 36(8):679-685. PubMed ID: 32268456
    [No Abstract]   [Full Text] [Related]  

  • 16. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: A case report from Bangladesh perspective.
    Jahan Y; Rahman S; Rahman A
    Respir Med Case Rep; 2020; 30():101068. PubMed ID: 32363143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-infection of COVID-19 and influenza A in a hemodialysis patient: a case report.
    Jing R; Vunnam RR; Schnaubelt E; Vokoun C; Cushman-Vokoun A; Goldner D; Vunnam SR
    BMC Infect Dis; 2021 Jan; 21(1):68. PubMed ID: 33441085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial.
    Koshak AE; Koshak EA; Mobeireek AF; Badawi MA; Wali SO; Malibary HM; Atwah AF; Alhamdan MM; Almalki RA; Madani TA
    Trials; 2020 Aug; 21(1):703. PubMed ID: 32771034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.